{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:54:52Z","timestamp":1786550092952,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.14309\/crj.2016.107","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T13:58:26Z","timestamp":1475071106000},"page":"e134","source":"Crossref","is-referenced-by-count":3,"title":["A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis"],"prefix":"10.14309","volume":"3","author":[{"given":"Shivali R.","family":"Berera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dholaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo R.","family":"Arosemena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Ladino-Avellaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan R.","family":"Bhamidimarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R1-134-20210317","first-page":"1164","article-title":"Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.","volume":"32","author":"Levine","year":"2005","journal-title":"J Rheumatol"},{"issue":"11","key":"R2-134-20210317","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"R3-134-20210317","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"R4-134-20210317","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-81-5-632","article-title":"Intestinal vasculitis in essential, mixed cryoglobulinemia.","volume":"81","author":"Reza","year":"1974","journal-title":"Ann Intern Med"},{"issue":"12","key":"R5-134-20210317","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1136\/gut.2010.218123","article-title":"Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: A case-control study from a singlecentre cohort of 163 patients.","volume":"59","author":"Terrier","year":"2010","journal-title":"Gut"},{"issue":"5","key":"R6-134-20210317","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1572-0241.2004.40061.x","article-title":"Gastrointestinal bleeding, cryoglobulinemia, and hepatitis C.","volume":"99","author":"Fine","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"R7-134-20210317","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"issue":"11","key":"R8-134-20210317","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1208642","article-title":"Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.","volume":"369","author":"Dammacco","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"R9-134-20210317","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ki.1994.393","article-title":"Renal manifestations of hepatitis C virus infection.","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int"},{"issue":"7","key":"R10-134-20210317","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.","volume":"328","author":"Johnson","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"R11-134-20210317","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: A long-term followup study.","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10","key":"R13-134-20210317","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia.","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"issue":"3","key":"R14-134-20210317","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"R15-134-20210317","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"R16-134-20210317","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virusinfected patients.","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"3","key":"R17-134-20210317","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: A long-term study.","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"2","key":"R18-134-20210317","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1995.03530020044018","article-title":"Dramatic worsening of hepatitis C virus-related cryoglobulinemia subsequent to treatment with interferon alfa.","volume":"274","author":"Harle","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"R19-134-20210317","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10620-013-2959-4","article-title":"De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature revieW).","volume":"59","author":"Fabrizi","year":"2014","journal-title":"Dig Dis Sci"}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201603000-00134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:14:08Z","timestamp":1786547648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201603000-00134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.2016.107","relation":{},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}